Creating a database for understanding peritoneal carcinosis
Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis
NA · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04221464
This study is collecting blood and tissue samples from adults with peritoneal carcinosis to understand the disease better and help create new treatments.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT04221464 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a prospective clinical and biological database focused on peritoneal carcinosis, a type of cancer that affects the peritoneum. By collecting blood and tissue samples from patients, researchers hope to gain insights into the mechanisms of carcinosis and develop targeted treatments. The study involves patients over 18 years old who are undergoing treatment for peritoneal carcinosis, ensuring that the data collected will be relevant and useful for future research. Informed consent is required from all participants to proceed with sample collection.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with peritoneal carcinosis from digestive origins who are undergoing treatment.
Not a fit: Patients who are not affiliated with a social protection system or those unable to comply with study requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to the development of more effective treatments for patients with peritoneal carcinosis.
How similar studies have performed: While this approach is focused on a specific type of cancer, similar studies have shown promise in understanding cancer mechanisms through biological databases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over the age of 18; * Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer * Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease * Patient agree will all study procedure : biological samples \& tissues samples * Patient giving informed consent Exclusion Criteria: * Patient not affiliated to Social Protection system * Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons * The level of French is insufficient to consent to the study and to response to the questionnaires * Patient under guardianship * Pregnancy ou breast-feeding women * Patient treated in case of an emergency
Where this trial is running
Montpellier
- Institut du cancer de Montpellier ICM — Montpellier, France (RECRUITING)
Study contacts
- Study coordinator: Aurore MOUSSION
- Email: aurore.moussion@icm.unicancer.fr
- Phone: 467613100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Peritoneal Carcinosis